Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Not Yet Recruiting

Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A

NCT06136507

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Children's Hospital Affiliated to Chongqing Medical University Chongqing, China
  • Guangzhou Women and Children Medical Center Guangzhou, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
  • Affiliated Hospital of Guizhou Medical University Guizhou, China
View all 13 locations
View Trial Details
Completed

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

NCT04684940

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +11 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Hemocentro Da UNICAMP Campinas, Brazil
  • Chaim Sheba Medical Center Ramat Gan, Israel
  • Kyung Hee University Hospital at Gangdong Seoul, South Korea
View Trial Details
Completed

A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog Alfa

NCT05817812

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Investigational Site Vienna, Austria
  • Investigational Site Zagreb, Croatia
  • Investigational Site Brno, Czechia
  • Investigational Site Prague, Czechia
View all 30 locations
View Trial Details
Completed

A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood

NCT05147662

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Children, +9 more
Locations
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Hospital de Niños Sor María Ludovica La Plata, Buenos Aires, Argentina
  • Instituo Hematología Arbesú Godoy Cruz, Mendoza Province, Argentina
  • Instituto de Hematología Dr. Rubén Dávoli Rosario, Santa Fe Province, Argentina
View all 18 locations
View Trial Details
Completed

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

NCT06579144

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Bonn, Germany
  • Sobi Investigational site Frankfurt, Germany
  • Sobi Investigational Site Milan, Italy
View Trial Details

Related conditions